0001493152-24-012650.txt : 20240402 0001493152-24-012650.hdr.sgml : 20240402 20240402092231 ACCESSION NUMBER: 0001493152-24-012650 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240327 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tevogen Bio Holdings Inc. CENTRAL INDEX KEY: 0001860871 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981597194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41002 FILM NUMBER: 24812439 BUSINESS ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 646-807-8832 MAIL ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Semper Paratus Acquisition Corp DATE OF NAME CHANGE: 20210505 8-K 1 form8-k.htm
false --12-31 0001860871 0001860871 2024-03-27 2024-03-27 0001860871 LGST:CommonStockParValue0.0001PerShareMember 2024-03-27 2024-03-27 0001860871 LGST:WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember 2024-03-27 2024-03-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 27, 2024

 

 

 

Tevogen Bio Holdings Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-41002   85-1284695

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

15 Independence Boulevard, Suite #410    
Warren, New Jersey   07059
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (877) 838-6436

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   TVGN   The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of Common Stock for $11.50 per share   TVGNW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

As previously disclosed, on February 14, 2024, the Company entered into a securities purchase agreement (the “Original Agreement”) with an investor (the “Investor”), pursuant to which the Investor purchased 500 shares of Series A Preferred Stock of the Company for an aggregate purchase price of $2.0 million. On March 27, 2024, the Company and the Investor entered into an Amended and Restated Securities Purchase Agreement, pursuant to which the parties amended and restated the Original Agreement and the Investor agreed to purchase 600 shares of Series A-1 Preferred Stock of the Company for an aggregate purchase price of $6.0 million.

 

The shares of Series A-1 Preferred Stock will be convertible into a total of 600,000 shares of the Company’s common stock at the election of the holder. The Series A-1 Preferred Stock will be subject to a call right providing the Company the right to call the stock if the volume weighted average price of the common stock for the 20 days prior to delivery of the call notice is greater than $5.00 per share and there is an effective resale registration statement on file covering the underlying common stock. The Series A-1 Preferred Stock will be non-voting, will have no mandatory redemption, and will carry an annual 5% cumulative dividend, increasing by 2% each year, but which in no event shall exceed 15% per annum. The Company also agreed that so long as the Series A-1 Preferred Stock is outstanding, the Company will not, without the written consent of the holders of 50.1% of the Series A-1 Preferred Stock, amend, alter, or repeal any provision of the Company’s certificate of incorporation or bylaws in a manner adverse to the Series A-1 Preferred Stock.

 

The Series A-1 Preferred Stock is being sold in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. The Investor is an entity associated with Dr. Manmohan Patel, an existing investor in the Company and beneficial owner of more than 5% of the Company’s common stock.

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On March 28, 2024, the Company filed the Certificate of Designation of Series A-1 Preferred Stock (the “Series A-1 Certificate of Designation”) with the Delaware Secretary of State, creating the Series A-1 Preferred Stock and establishing the rights, preferences and other terms of the Series A-1 Preferred Stock, and issued the Series A-1 Preferred Stock. A summary of the material terms of the Series A-1 Certificate of Designation is set forth below.

 

Security   Series A-1 Preferred Stock, par value $0.0001 per share
     
Ranking, with respect to rights as to as to dividends, distributions, redemptions and payments upon the liquidation, dissolution and winding up of the Company   The Series A-1 Preferred Stock ranks pari passu to the Company’s Series A Preferred Stock and senior to all the Company’s Common Stock and Series B Preferred Stock with respect to dividend rights and rights on the distribution of assets upon liquidation, dissolution and winding up.
     
Original Issue Price   $10,000 per share of Series A-1 Preferred Stock.
     
Dividend   Holders of Series A-1 Preferred Stock are entitled to receive dividends accruing daily on a cumulative basis payable at a fixed rate of 5% per annum per share on the Original Issue Price, which rate will automatically increase by 2% every year that the Series A-1 Preferred Stock remains outstanding but in no event shall exceed 15% per annum. The Series A-1 Preferred Stock will also participate on an as-converted basis in any regular or special dividends paid to holders of the Common Stock.
     
Redemption   The Series A-1 Preferred Stock is subject the Company’s right to call the Series A-1 Preferred Stock for $10,000.00 per share plus any Accruing Dividends accrued but unpaid thereon if the volume weighted average price of the Common Stock for the twenty days prior to delivery of the Call Notice is greater than $5.00 per share and there is an effective resale registration statement on file covering the underlying Common Stock.
     

Conversion Rights

 

  The holders of the Series A-1 Preferred Stock may elect to convert the Series A-1 Preferred Stock into shares of the Common Stock, at the applicable conversion rate (subject to certain adjustments), at any time, which right is subject to termination upon a Deemed Liquidation Event or a liquidation, dissolution or winding up of the Company.

 

2

 

 

Consent Rights   As long as the Series A-1 Preferred Stock is outstanding, the Company will not, without the written consent of the holders of 50.1% of the Series A-1 Preferred Stock, amend, alter, or repeal any provision of the Company’s Certificate of Incorporation or Bylaws in a manner adverse to the Series A-1 Preferred Stock.
     
Voting   The holders of outstanding shares of Series A-1 Preferred Stock shall have no voting rights with respect to such shares of Series A-1 Preferred Stock on any matter presented to the Company’s stockholders, except as required by law or as specifically set forth in the Certificate of Designation.
     
Liquidation Preference   In the event of a liquidation, dissolution or winding up of the Company or a Deemed Liquidation Event, the Company is required to first pay the Series A-1 Preferred Stock holders an amount per share equal to the greater of (i) the Original Issue Price plus Accruing Dividends accrued but unpaid on each share of Series A-1 Preferred Stock and (ii) such amount per share as would have been payable had all shares of Series A-1 Preferred Stock been converted into Common Stock immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation Event.
     
No Maturity and No Sinking Fund   The Series A-1 Preferred Stock will have no stated maturity and will not be subject to any sinking fund.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit  

Description

3.1   Certificate of Designation of Series A-1 Preferred Stock of Tevogen Bio Holdings Inc.
10.1   Amended and Restated Securities Purchase Agreement, dated as of March 27, 2024, by and among Tevogen Bio Holdings Inc. and The Patel Family, LLP
104.1   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Tevogen Bio Holdings Inc.
     
Date: April 2, 2024 By: /s/ Ryan Saadi
  Name: Ryan Saadi
  Title: Chief Executive Officer

 

4

 

EX-3.1 2 ex3-1.htm

 

Exhibit 3.1

 

CERTIFICATE OF DESIGNATION

OF

SERIES A-1

PREFERRED STOCK,

PAR VALUE $0.0001 PER SHARE,

OF

TEVOGEN BIO HOLDINGS INC.

 

Pursuant to the provisions of Section 151 of the General Corporation Law of the State of Delaware (the “DGCL”), Tevogen Bio Holdings Inc., a corporation organized and existing under the DGCL (hereinafter called the “Corporation”), in accordance with the provisions of Section 103, does hereby submit the following:

 

WHEREAS, the Certificate of Incorporation of the Corporation (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Certificate”) authorizes the issuance of Preferred Stock, par value $0.0001 per share, of the Corporation (“Preferred Stock”) in one or more series; and expressly authorizes the Board of Directors of the Corporation (the “Board” or “Board of Directors”), subject to limitations prescribed by the requirements of law to provide, out of the unissued shares of Preferred Stock, for series of Preferred Stock, and with respect to each such series, to establish and fix the number of shares to be included in any series of Preferred Stock and the designations, rights and preferences of the shares of such series; and

 

WHEREAS, the Corporation hereby certifies that the following resolution was adopted by the pricing committee of the Board of Directors, acting in accordance with resolutions of the Board of Directors, by action duly taken on March 27, 2024:

 

RESOLVED, that pursuant to the DGCL and the Bylaws of the Corporation (the “Bylaws”), the Board hereby creates as a series of Preferred Stock and authorizes 600 shares of Preferred Stock of the Corporation to be designated “Series A-1 Preferred Stock”, each with the following rights, preferences, powers, privileges and restrictions, qualifications and limitations:

 

1. Number of Shares.

 

The number of authorized shares of Series A-1 Preferred stock shall be 600. Subject to the provisions of Section 4, that number from time to time may be increased or decreased (but not below the number of shares of Series A-1 Preferred Stock then outstanding) by (a) further resolution duly adopted by the Board, or any duly authorized committee thereof, and (b) the filing of an amendment to this Certificate of Designation (“Certificate of Designation”) pursuant to the provisions of the DGCL stating that such increase or decrease, as applicable, has been so authorized.

 

 
 

 

2. Dividends.

 

From and after the date of the issuance of any shares of Series A-1 Preferred Stock, dividends at the rate per annum of 5% of the Original Issue Price (as defined below) of such share, plus the amount of previously accrued dividends, compounded annually, shall accrue on each share then outstanding (the “Accruing Dividends”). The rate per annum of the Accruing Dividends shall increase by 2% of the Original Issue Price each year on the date of issuance of such shares of Series A-1 Preferred Stock, but in no event shall exceed 15% per annum. Accruing Dividends shall accrue from day to day, whether or not declared, and shall be cumulative. The Corporation shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock of the Corporation (other than dividends on shares of Common Stock payable in shares of Common Stock or dividends on Series A Preferred Stock or Series B Preferred Stock) unless (in addition to the obtaining of any consents required elsewhere in the Certificate of Incorporation) the holders of the Series A-1 Preferred Stock then outstanding shall first receive, or simultaneously receive, a dividend on each outstanding share of Series A-1 Preferred Stock in an amount at least equal to (i) the amount of the aggregate Accruing Dividends then accrued on such share of Series A-1 Preferred Stock and not previously paid and (ii) (A) in the case of a dividend on Common Stock or any class or series that is convertible into Common Stock, that dividend per share of Series A-1 Preferred Stock as would equal the product of (1) the dividend payable on each share of such class or series determined, if applicable, as if all shares of such class or series had been converted into Common Stock and (2) the number of shares of Common Stock issuable upon conversion of a share of Series A-1 Preferred Stock, in each case calculated on the record date for determination of holders entitled to receive such dividend or (B) in the case of a dividend on any class or series that is not convertible into Common Stock, at a rate per share of Series A-1 Preferred Stock determined by (1) dividing the amount of the dividend payable on each share of such class or series of capital stock by the original issuance price of such class or series of capital stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to such class or series) and (2) multiplying such fraction by an amount equal to the applicable Original Issue Price (as defined below); provided that if the Corporation declares, pays or sets aside, on the same date, a dividend on shares of more than one class or series of capital stock of the Corporation, the dividend payable to the holders of Series A-1 Preferred Stock pursuant to this Section 2 shall be calculated based upon the dividend on the class or series of capital stock that would result in the highest dividend for Series A-1 Preferred Stock. The “Original Issue Price” shall mean, with respect to the Series A-1 Preferred Stock, $10,000.00 per share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series A-1 Preferred Stock.

 

3. Liquidation, Dissolution or Winding Up; Certain Mergers, Consolidations and Asset Sales.

 

3.1 Preferential Payments to Holders of Series A-1 Preferred Stock. In the event of (a) any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of shares of Series A-1 Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Corporation available for distribution to its stockholders, and (b) a Deemed Liquidation Event (as defined in Section 3.3.1 below), the holders of shares of Series A-1 Preferred Stock then outstanding shall be entitled to be paid out of the consideration payable to stockholders in such Deemed Liquidation Event or out of the Available Proceeds (as defined in Section 3.3.2(b) below), as applicable, in each case on a pari passu basis with the Series A Preferred Stock based on their respective Liquidation Amounts (as defined below), but before any payment on the Series B Preferred Stock or Series C Preferred Stock, each of which rank junior to the Series A-1 Preferred Stock and Series A Preferred Stock in all respects, and before any payment shall be made to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the greater of (i) the Original Issue Price, plus any Accruing Dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon, or (ii) such amount per share as would have been payable had all shares of Series A-1 Preferred Stock or Series A Preferred Stock, respectively, been converted into Common Stock pursuant to Section 5 immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation Event (the amount payable pursuant to this sentence is hereinafter referred to as the “Liquidation Amount”). If upon any such liquidation, dissolution or winding up of the Corporation or Deemed Liquidation Event, the assets of the Corporation available for distribution to its stockholders shall be insufficient to pay the holders of shares of Series A-1 Preferred Stock and Series A Preferred Stock the full amount to which they shall be entitled under this Section 3.1, the holders of shares of Series A-1 Preferred Stock and Series A Preferred Stock, respectively, shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.

 

 
 

 

3.2 Payments to Holders of Series B Preferred Stock, Series C Preferred Stock and Common Stock. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, after the payment in full of all Liquidation Amounts required to be paid to the holders of shares of Series A-1 Preferred Stock and Series A Preferred Stock, the remaining assets of the Corporation available for distribution to its stockholders or, in the case of a Deemed Liquidation Event, the consideration not payable to the holders of shares of Series A-1 Preferred Stock and Series A Preferred Stock pursuant to Section 3.1 or the remaining Available Proceeds, as the case may be, shall be distributed first, among the holders of shares of Series B Preferred Stock and Series C Preferred Stock on a pari passu basis based on their Liquidation Amounts, and second, among the holders of shares of Common Stock, pro rata based on the number of shares of Common Stock held by each such holder.

 

3.3 Deemed Liquidation Events.

 

3.3.1 Definition. Each of the following events shall be considered a “Deemed Liquidation Event” unless the holders of at least 50.1% of the outstanding shares of Series A Preferred Stock, voting on an as converted to Common Stock basis (the “Requisite Holders”), elect otherwise by written notice sent to the Corporation at least 10 days prior to the effective date of any such event:

 

(a) a merger, consolidation, statutory conversion, transfer, domestication, or continuance in which

 

  (i) the Corporation is a constituent party or

 

  (ii) a subsidiary of the Corporation is a constituent party and the Corporation issues shares of its capital stock pursuant to such merger, consolidation, statutory conversion, transfer, domestication, or continuance,

 

except any such merger, consolidation, statutory conversion, transfer, domestication, or continuance involving the Corporation or a subsidiary in which the shares of capital stock of the Corporation outstanding immediately prior to such merger, consolidation, statutory conversion, transfer, domestication, or continuance continue to represent, or are converted into or exchanged for shares of capital stock or other equity interests that represent, immediately following such merger, consolidation, statutory conversion, transfer, domestication, or continuance, a majority, by voting power, of the capital stock or other equity interests of (1) the surviving or resulting corporation or entity; or (2) if the surviving or resulting corporation or entity is a wholly owned subsidiary of another corporation or entity immediately following such merger, consolidation, statutory conversion, transfer, domestication, or continuance, the parent corporation or entity of such surviving or resulting corporation or entity; or

 

 
 

 

(b) (i) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Corporation or any subsidiary of the Corporation of all or substantially all the assets of the Corporation and its subsidiaries taken as a whole or (ii) the sale, lease, transfer, exclusive license or other disposition (whether by merger, consolidation, statutory conversion, domestication, continuance or otherwise, and whether in a single transaction or a series of related transactions) of one or more subsidiaries of the Corporation if substantially all of the assets of the Corporation and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Corporation.

 

3.3.2 Effecting a Deemed Liquidation Event.

 

(a) The Corporation shall not have the power to effect a Deemed Liquidation Event referred to in Section 3.3.(a)(i) unless the agreement or plan with respect to such transaction, or terms of such transaction (any such agreement, plan or terms, the “Transaction Document”) provide that the consideration payable to the stockholders of the Corporation in such Deemed Liquidation Event shall be allocated to the holders of capital stock of the Corporation in accordance with Sections 3.1 and 3.2.

 

(b) In the event of a Deemed Liquidation Event referred to in Section 3.3.1(a)(ii) or 3.3.1(b), if the Corporation does not effect a dissolution of the Corporation under the General Corporation Law within 90 days after such Deemed Liquidation Event, then (i) the Corporation shall send a written notice to each holder of Series A-1 Preferred Stock no later than the 90th day after the Deemed Liquidation Event advising such holders of their right (and the requirements to be met to secure such right) pursuant to the terms of the following clause, (ii) to require the redemption of such shares of Series A-1 Preferred Stock, and (iii) if the Requisite Holders so request in a written instrument delivered to the Corporation not later than 120 days after such Deemed Liquidation Event, the Corporation shall use the consideration received by the Corporation for such Deemed Liquidation Event (net of any retained liabilities associated with the assets sold or technology licensed, any other expenses reasonably related to such Deemed Liquidation Event or any other expenses incident to the dissolution of the Corporation as provided herein, in each case as determined in good faith by the Board of Directors), together with any other assets of the Corporation available for distribution to its stockholders, all to the extent permitted by Delaware law governing distributions to stockholders (the “Available Proceeds”) on the 150th day after such Deemed Liquidation Event (the “DLE Redemption Date”), to redeem all outstanding shares of Series A-1 Preferred Stock at a price per share equal to the applicable Liquidation Amount; provided, that if the definitive agreements governing such Deemed Liquidation Event contain contingent indemnification obligations on the part of the Corporation and prohibit the Corporation from distributing all or a portion of the Available Proceeds while such indemnification obligations remain outstanding, then the DLE Redemption Date shall automatically be extended to the date that is ten business days following the date on which such prohibition expires. Notwithstanding the foregoing, in the event of a redemption pursuant to the preceding sentence, if the Available Proceeds are not sufficient to redeem all outstanding shares of Series A-1 Preferred Stock, the Corporation shall redeem a pro rata portion of each holder’s shares of Series A-1 Preferred Stock to the fullest extent of such Available Proceeds, based on the respective amounts which would otherwise be payable in respect of the shares to be redeemed if the Available Proceeds were sufficient to redeem all such shares, and shall redeem the remaining shares as soon as it may lawfully do so under Delaware law governing distributions to stockholders. Prior to the distribution or redemption provided for in this Section 3.3.2(b), the Corporation shall not expend or dissipate the Available Proceeds for any purpose, except to discharge expenses incurred in connection with such Deemed Liquidation Event. In connection with a distribution or redemption provided for in Section 3.3.2, the Corporation shall send written notice of the redemption (the “Redemption Notice”) to each holder of record of Series A-1 Preferred Stock. Each Redemption Notice shall state:

 

  (i) the number of shares of Series A-1 Preferred Stock held by the holder that the Corporation shall redeem on the date specified in the Redemption Notice;

 

 
 

 

  (ii) the redemption date and the price per share at which the shares of Series A-1 Preferred Stock are being redeemed;

 

  (iii) for holders of shares in certificated form, that the holder is to surrender to the Corporation, in the manner and at the place designated, his, her or its certificate or certificates representing the shares of Series A-1 Preferred Stock to be redeemed.

 

If the Redemption Notice shall have been duly given, and if payment is tendered or deposited with an independent payment agent so as to be available therefor in a timely manner, then notwithstanding that any certificates evidencing any of the shares of Series A-1 Preferred Stock so called for redemption shall not have been surrendered, all rights with respect to such shares shall forthwith after the date terminate, except only the right of the holders to receive the payment without interest upon surrender of any such certificate or certificates therefor.

 

3.3.3 Amount Deemed Paid or Distributed. The amount deemed paid or distributed to the holders of capital stock of the Corporation upon any such merger, consolidation, sale, transfer, exclusive license, other disposition or redemption shall be the cash or the value of the property, rights or securities to be paid or distributed to such holders pursuant to such Deemed Liquidation Event. The value of such property, rights or securities shall be determined in good faith by the Board of Directors.

 

3.3.4 Allocation of Escrow and Contingent Consideration. In the event of a Deemed Liquidation Event pursuant to Section 3.3.1(a)(i), if any portion of the consideration payable to the stockholders of the Corporation is payable only upon satisfaction of contingencies (the “Additional Consideration”), the Transaction Document shall provide that (a) the portion of such consideration that is not Additional Consideration (such portion, the “Initial Consideration”) shall be allocated among the holders of capital stock of the Corporation in accordance with Sections 3.1 and 3.2 as if the Initial Consideration were the only consideration payable in connection with such Deemed Liquidation Event; and (b) any Additional Consideration which becomes payable to the stockholders of the Corporation upon satisfaction of such contingencies shall be allocated among the holders of capital stock of the Corporation in accordance with Sections 3.1 and 3.2 after taking into account the previous payment of the Initial Consideration as part of the same transaction. For the purposes of this Section 3.3.4, consideration placed into escrow or retained as a holdback to be available for satisfaction of indemnification or similar obligations in connection with such Deemed Liquidation Event shall be deemed to be Additional Consideration.

 

 
 

 

4. Voting.

 

4.1 General. The holders of outstanding shares of Series A-1 Preferred Stock shall have no voting rights with respect to such shares of Series A-1 Preferred Stock on any matter presented to the stockholders of the Corporation for their action or consideration at any meeting of stockholders of the Corporation (or by written consent of stockholders in lieu of a meeting), except as required by law or as specifically set forth in this Certificate of Designation. For any matter which the holders of shares of Series A-1 Preferred Stock are required by law or entitled pursuant to this Certificate of Designation to vote, each holder of outstanding shares of Series A-1 Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series A-1 Preferred Stock held by such holder are convertible (as provided in Section 5 below) as of the record date for determining stockholders entitled to vote on such matter. Except as provided by law or by the other provisions of the Certificate of Incorporation, holders of Series A-1 Preferred Stock shall vote together with the holders of Common Stock as a single class and on an as-converted to Common Stock basis on matters on which they are required by law or entitled pursuant to this Certificate of Designation to vote.

 

4.2 Series A-1 Preferred Stock Protective Provisions. At any time when shares of Series A-1 Preferred Stock are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation, domestication, transfer, continuance, recapitalization, reclassification, waiver, statutory conversion or otherwise, effect any of the following acts or transactions without (in addition to any other vote required by law or the Certificate of Incorporation) the written consent or affirmative vote of the Requisite Holders, and any such act or transaction that has not been approved by such consent or vote prior to such act or transaction being effected shall be null and void ab initio, and of no force or effect.

 

4.2.1 amend, alter or repeal any provision of the Certificate of Incorporation or Bylaws of the Corporation in a manner that adversely affects the special rights, powers and preferences of the Series A-1 Preferred Stock.

 

 
 

 

5. Optional Conversion.

 

The holders of the Series A-1 Preferred Stock shall have conversion rights as follows (the “Conversion Rights”):

 

5.1 Right to Convert.

 

5.1.1 Conversion Ratio. Each share of Series A-1 Preferred Stock shall be convertible, at the option of the holder thereof, at any time, and without the payment of additional consideration by the holder thereof, into such whole number of fully paid and non-assessable shares of Common Stock (calculated as provided in Section 5.2 below), as is determined by dividing the applicable Original Issue Price by the Conversion Price (as defined below) in effect at the time of conversion. The “Conversion Price” applicable to the Series A-1 Preferred Stock as of the Original Issue Date shall be equal to $10.00. Such initial Conversion Price and the rate at which shares of Series A-1 Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment as provided in this Section 5.

 

5.1.2 Termination of Conversion Rights. In the event of a notice of redemption of any shares of Series A-1 Preferred Stock pursuant to Section 3.3.2(b), the Conversion Rights of the shares designated for redemption shall terminate at the close of business on the last full day preceding the date fixed for redemption, unless the redemption price is not fully paid on such redemption date, in which case the Conversion Rights for such shares shall continue until such price is paid in full. In the event of a liquidation, dissolution or winding up of the Corporation or a Deemed Liquidation Event, the Conversion Rights shall terminate at the close of business on the last full day preceding the date fixed for the payment of any such amounts distributable on such event to the holders of Series A-1 Preferred Stock; provided that the foregoing termination of Conversion Rights shall not affect the amount(s) otherwise paid or payable in accordance with Section 3.1 to the holders of Series A-1 Preferred Stock pursuant to such liquidation, dissolution or winding up of the Corporation or a Deemed Liquidation Event.

 

5.2 Number of Shares Issuable Upon Conversion. The number of shares of Common Stock issuable to a holder of Series A-1 Preferred Stock upon conversion of such Series A-1 Preferred Stock shall be the nearest whole share, after aggregating all fractional interests in shares of Common Stock that would otherwise be issuable upon conversion of all shares of Series A-1 Preferred Stock being converted by such holder (with any fractional interests after such aggregation representing 0.5 or greater of a whole share being entitled to a whole share) .. For the avoidance of doubt, no fractional interests in shares of Common Stock shall be created or issuable as a result of the conversion of the Series A-1 Preferred Stock pursuant to Section 5.1.1.

 

5.3 Mechanics of Conversion.

 

5.3.1 Notice of Conversion. In order for a holder of Series A-1 Preferred Stock to voluntarily convert such shares of Series A-1 Preferred Stock into shares of Common Stock, such holder shall (a) provide written notice to the Corporation at the principal office of the Corporation if the Corporation serves as its own transfer agent that such holder elects to convert all or any number of such holder’s shares of Series A-1 Preferred Stock and, if applicable, any event on which such conversion is contingent and (b) if such holder’s shares are certificated, surrender the certificate or certificates for such shares of Series A-1 Preferred Stock (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate), at the principal office of the Corporation. Such notice shall state such holder’s name or the names of the nominees in which such holder wishes the shares of Common Stock to be issued. If required by the Corporation, any certificates surrendered for conversion shall be endorsed or accompanied by a written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder or his, her or its attorney duly authorized in writing. Unless a later time and date is otherwise specified by the Corporation, the close of business on the date of receipt by the Corporation of such notice and, if applicable, certificates (or lost certificate affidavit and agreement) shall be the time of conversion (the “Conversion Time”), and the shares of Common Stock issuable upon conversion of the specified shares shall be deemed to be outstanding of record as of such date. The Corporation shall, as soon as practicable after the Conversion Time (i) issue and deliver to such holder of Series A-1 Preferred Stock, or to such holder’s nominees, a notice of issuance of uncertificated shares and may, upon written request, issue and deliver a certificate for the number of full shares of Common Stock issuable upon such conversion in accordance with the provisions hereof and, may, if applicable and upon written request, issue and deliver a certificate for the number (if any) of the shares of Series A-1 Preferred Stock represented by any surrendered certificate that were not converted into Common Stock, and (ii) pay all declared but unpaid dividends on the shares of Series A-1 Preferred Stock converted.

 

 
 

 

5.3.2 Reservation of Shares. The Corporation shall at all times when the Series A-1 Preferred Stock shall be outstanding, reserve and keep available out of its authorized but unissued capital stock, for the purpose of effecting the conversion of the Series A-1 Preferred Stock, such number of its duly authorized shares of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding Series A-1 Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of the Series A-1 Preferred Stock, the Corporation shall take such corporate action as may be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including, without limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Certificate of Incorporation. Before taking any action which would cause an adjustment reducing the Conversion Price below the then par value of the shares of Common Stock issuable upon conversion of such series of Series A-1 Preferred Stock, the Corporation will take any corporate action which may, in the opinion of its counsel, be necessary in order that the Corporation may validly and legally issue fully paid and non assessable shares of Common Stock at such adjusted Conversion Price.

 

5.3.3 Effect of Conversion. All shares of Series A-1 Preferred Stock which shall have been surrendered for conversion as herein provided shall no longer be deemed to be outstanding and all rights with respect to such shares shall immediately cease and terminate at the Conversion Time, except only the right of the holders thereof to receive shares of Common Stock in exchange therefor and to receive payment of any Accruing Dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon.

 

5.3.4 No Further Adjustment. Upon any such conversion, no adjustment to the Conversion Price shall be made for any declared but unpaid dividends on the Series A-1 Preferred Stock surrendered for conversion or on the Common Stock delivered upon conversion.

 

5.3.5 Taxes. The Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or delivery of shares of Common Stock upon conversion of shares of Series A-1 Preferred Stock pursuant to this Section 5. The Corporation shall not, however, be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Series A-1 Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person or entity requesting such issuance has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid.

 

 
 

 

5.4 Adjustment for Stock Splits and Combinations. If the Corporation shall at any time or from time to time after the Original Issue Date effect a subdivision of the outstanding Common Stock, the Conversion Price in effect immediately before that subdivision shall be proportionately decreased so that the number of shares of Common Stock issuable on conversion of each share of such series shall be increased in proportion to such increase in the aggregate number of shares of Common Stock outstanding. If the Corporation shall at any time or from time to time after the Original Issue Date combine the outstanding shares of Common Stock, the Conversion Price in effect immediately before the combination shall be proportionately increased so that the number of shares of Common Stock issuable on conversion of each share of Series A-1 Preferred Stock shall be decreased in proportion to such decrease in the aggregate number of shares of Common Stock outstanding. Any adjustment under this Section 5.4 shall become effective at the close of business on the date the subdivision or combination becomes effective.

 

5.5 Adjustment for Certain Dividends and Distributions. In the event the Corporation at any time or from time to time after the Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable on the Common Stock in additional shares of Common Stock, then and in each such event the Conversion Price in effect immediately before such event shall be decreased as of the time of such issuance or, in the event such a record date shall have been fixed, as of the close of business on such record date, by multiplying the Conversion Price then in effect by a fraction:

 

(1) the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and

 

(2) the denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend or distribution.

 

Notwithstanding the foregoing, (a) if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, the Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Conversion Price shall be adjusted pursuant to this Section 5.5 as of the time of actual payment of such dividends or distributions; and (b) no such adjustment shall be made if the holders of Series A-1 Preferred Stock simultaneously receive a dividend or other distribution of shares of Common Stock in a number equal to the number of shares of Common Stock as they would have received if all outstanding shares of Series A-1 Preferred Stock had been converted into Common Stock on the date of such event.

 

 
 

 

5.6 Adjustments for Other Dividends and Distributions. In the event the Corporation at any time or from time to time after the Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in securities of the Corporation (other than a distribution of shares of Common Stock in respect of outstanding shares of Common Stock) or in other property and the provisions of Section 2 do not apply to such dividend or distribution, then and in each such event the holders of Series A-1 Preferred Stock shall receive, simultaneously with the distribution to the holders of Common Stock, a dividend or other distribution of such securities or other property in an amount equal to the amount of such securities or other property as they would have received if all outstanding shares of Series A-1 Preferred Stock had been converted into Common Stock on the date of such event.

 

5.7 Adjustment for Merger or Reorganization, etc. Subject to the provisions of Section 3.3, if there shall occur any reorganization, recapitalization, reclassification, consolidation or merger involving the Corporation in which the Common Stock (but not the Series A-1 Preferred Stock) is converted into or exchanged for securities, cash or other property (other than a transaction covered by Sections 5.5 or 5.6), then, following any such reorganization, recapitalization, reclassification, consolidation or merger, each share of Series A-1 Preferred Stock shall thereafter be convertible in lieu of the Common Stock into which it was convertible prior to such event into the kind and amount of securities, cash or other property which a holder of the number of shares of Common Stock of the Corporation issuable upon conversion of one share of Series A-1 Preferred Stock immediately prior to such reorganization, recapitalization, reclassification, consolidation or merger would have been entitled to receive pursuant to such transaction; and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors) shall be made in the application of the provisions in this Section 5 with respect to the rights and interests thereafter of the holders of the Series A-1 Preferred Stock, to the end that the provisions set forth in this Section 5 (including provisions with respect to changes in and other adjustments of the Conversion Price) shall thereafter be applicable, as nearly as reasonably may be, in relation to any securities or other property thereafter deliverable upon the conversion of the Series A-1 Preferred Stock.

 

5.8 Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment of the Conversion Price pursuant to this Section 5, the Corporation at its expense shall, as promptly as reasonably practicable but in any event not later than 10 days thereafter, compute such adjustment or readjustment in accordance with the terms hereof and furnish to each holder of such series of Series A-1 Preferred Stock a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property into which such series of Series A-1 Preferred Stock is convertible) and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation shall, as promptly as reasonably practicable after the written request at any time of any holder of Series A-1 Preferred Stock (but in any event not later than 10 days thereafter), furnish or cause to be furnished to such holder a certificate setting forth (i) the Conversion Price then in effect, and (ii) the number of shares of Common Stock and the amount, if any, of other securities, cash or property which then would be received upon the conversion of each share of each series of Series A-1 Preferred Stock.

 

5.9 Notice of Record Date. In the event:

 

(a) the Corporation shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon conversion of the Series A-1 Preferred Stock) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of capital stock of any class or series or any other securities, or to receive any other security; or

 

 
 

 

(b) of any capital reorganization of the Corporation, any reclassification of the Common Stock of the Corporation, or any Deemed Liquidation Event; or

 

(c) of the voluntary or involuntary dissolution, liquidation or winding-up of the Corporation,

 

then, and in each such case, the Corporation will send or cause to be sent to the holders of the Series A-1 Preferred Stock a notice specifying, as the case may be, (i) the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (ii) the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up is proposed to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such other capital stock or securities at the time issuable upon the conversion of the Series A-1 Preferred Stock) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up, and the amount per share and character of such exchange applicable to the Series A-1 Preferred Stock and the Common Stock. Such notice shall be sent at least 10 days prior to the record date or effective date for the event specified in such notice.

 

6. Call Right.

 

6.1 General. Each share of Series A-1 Preferred Stock shall be redeemable at the election of the Corporation (the “Call Right”).

 

6.2 Notice of Call. To exercise the Call Right, the Corporation shall send written notice (the “Call Notice”) to the applicable holder of record of Series A-1 Preferred Stock not less than 15 days prior to the proposed effective date for exercise of such Call Right (the “Call Date”), provided that the Call Notice cannot be delivered unless:

 

(a) the volume-weighted average price of the Common Stock for the 20 trading days prior to delivery of the Call Notice is greater than $5.00 per share (subject to adjustments for stock dividends, splits, combinations and similar events); and

 

(b) there at the time of such delivery there is an effective registration statement registering the resale by each holder of record of the Series A-1 Preferred Stock of the shares of Common Stock into which the Series A-1 Preferred Stock is convertible.

 

After delivery of the Call Notice but prior to the Call Date, each holder of Series A-1 Preferred Stock may exercise their Conversion Rights pursuant to Section 5, and no Call Notice shall be effective with respect to any share of Series A-1 Preferred Stock for which the Conversion Time occurs prior to the Call Date.

 

6.3 Call Notice Information. Each Call Notice shall state:

 

(a) the price per share of each share of Series A-1 Preferred Stock subject to the Call Right then being exercised by the Corporation, which shall be equal to $10,000.00, plus any Accruing Dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon as of (the “Call Price”);

 

 
 

 

(b) the number of shares of Series A-1 Preferred Stock held by the holder that the Corporation shall call on the Call Date specified in the Call Notice;

 

(c) the Call Date and the Call Price;

 

(d) the date upon which the holder’s right to convert such shares terminates (as determined in accordance with Section 5), if any; and

 

(e) for holders of shares in certificated form, that the holder is to surrender to the Corporation, in the manner and at the place designated, his, her or its certificate or certificates representing the shares of Series A-1 Preferred Stock to be redeemed.

 

6.4 Surrender of Certificates; Payment. On or before the applicable Call Date, each holder of shares of Series A-1 Preferred Stock to be called on such Call Date, unless such holder has exercised his, her or its right to convert such shares as provided in Section 5 shall, if a holder of shares in certificated form, surrender the certificate or certificates representing such shares (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to the Corporation, in the manner and at the place designated in the Call Notice, and thereupon the Call Price for such shares shall be payable to the order of the person whose name appears on such certificate or certificates as the owner thereof. In the event less than all of the shares of Series A-1 Preferred Stock represented by a certificate are redeemed, a new certificate, instrument, or book entry representing the unredeemed shares of Series A-1 Preferred Stock shall promptly be issued to such holder.

 

6.5 Rights Subsequent to Call. If the Call Notice shall have been duly given, and if on the applicable Call Date the Call Price payable upon redemption of the shares of Series A-1 Preferred Stock to be redeemed on such Call Date is paid or tendered for payment or deposited with an independent payment agent so as to be available therefor in a timely manner, then notwithstanding that any certificates evidencing any of the shares of Series A-1 Preferred Stock so called shall not have been surrendered, dividends with respect to such shares of Series A-1 Preferred Stock shall cease to accrue after such Call Date and all rights with respect to such shares shall forthwith after the Call Date terminate, except only the right of the holders to receive the Call Price without interest upon surrender of any such certificate or certificates therefor.

 

7. Redeemed or Otherwise Acquired Shares. Unless approved by the Board of Directors and the Requisite Holders, any shares of Series A-1 Preferred Stock that are redeemed, converted or otherwise acquired by the Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not be reissued, sold or transferred. Neither the Corporation nor any of its subsidiaries may exercise any voting or other rights granted to the holders of Series A-1 Preferred Stock following redemption, conversion or acquisition. The Corporation may thereafter take such appropriate action (without the need for stockholder action) as may be necessary to reduce the authorized number of shares of Series A-1 Preferred Stock accordingly.

 

8. Waiver. Except as otherwise set forth herein, any of the rights, powers, preferences and other terms of the Series A-1 Preferred Stock set forth herein may be waived on behalf of all holders of such Series A-1 Preferred Stock by the affirmative written consent or vote of the holders that would otherwise be required to amend such right, powers, preferences, and other terms.

 

9. Notices. Any notice required or permitted by the provisions of this Certificate of Designation to be given to a holder of shares of Series A-1 Preferred Stock shall be mailed, postage prepaid, to the post office address last shown on the records of the Corporation, or given by electronic transmission in compliance with the provisions of the DGCL, and shall be deemed sent upon such mailing or electronic transmission.

 

 

 

EX-10.1 3 ex10-1.htm

 

Exhibit 10.1

 

Amended and restated

 

Securities Purchase AGREEMENT

 

This amended and resTated SECURITIES PURCHASE Agreement (this “Agreement”) is made as of March 27, 2024, by and among Tevogen Bio Holdings Inc., a Delaware corporation (the “Company”), and The Patel Family, LLP (“Purchaser”), and amends and restates in its entirety that certain Securities Purchase Agreement made as of February 14, 2024 by among the Company and Purchaser (the “Original Agreement”).

 

For this and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

1. Sale and Purchase. The Company previously issued and sold to Purchaser, and Purchaser purchased from the Company, 500 shares of the Company’s previously designated Series A Preferred Stock (the “Series A Preferred Shares”), for an aggregate purchase price of $2,000,000 (the “Initial Purchase Price”). Purchaser previously paid the Initial Purchase Price pursuant to the Original Agreement. The Company shall issue and sell to Purchase, and Purchaser shall purchase from the Company 600 shares of the Company’s Series A-1 Preferred Stock (the “Series A-1 Preferred Shares” and together with the Series A Preferred Shares, the “Preferred Shares”), for an aggregate purchase price of $6,000,000 (the “Second Purchase Price”). Purchaser shall pay the Second Purchase Price, via wire transfer of immediately available funds pursuant to the wire instructions previously delivered by the Company, within one business day of the date hereof.

 

2. Company Representations and Warranties. The Company hereby represents, warrants, acknowledges, and agrees as follows:

 

(a) Organization and Corporate Power. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to enter into and consummate the transactions contemplated by this Agreement and to carry on its business as presently conducted.

 

(b) Binding Obligation. This Agreement, when executed and delivered by the Company, shall constitute a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms except as limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, or (ii) laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

3. Purchaser Representations and Warranties. Purchaser hereby represents, warrants, acknowledges, and agrees as follows:

 

(a) Authorization. Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by Purchaser, will constitute a valid and legally binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms, except as limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or any other laws of general application affecting enforcement of creditors’ rights generally, or (ii) laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

 
 

 

(b) Purchase Entirely for Own Account. This Agreement is made with Purchaser in reliance upon Purchaser’s representation to the Company, which by Purchaser’s execution of this Agreement, Purchaser hereby confirms, that the Preferred Shares have been and will be acquired for investment for Purchaser’s own account, and not with a view to the resale or distribution of any part thereof, and that Purchaser has no direct or indirect arrangement or understanding with any other persons to distribute or regarding the distribution of the Preferred Shares. Purchaser has not been formed for the specific purpose of acquiring the Preferred Shares.

 

(c) Disclosure of Information. Purchaser acknowledges that it has been afforded: (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Preferred Shares and the merits and risks of investing in the Preferred Shares; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.

 

(d) Restricted Securities. Purchaser understands that the Preferred Shares are not, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”). Purchaser understands that the Preferred Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, Purchaser may not sell the Preferred Shares unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or unless an exemption from such registration and qualification requirements is available. Purchaser acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Preferred Shares, delivery of a legal opinion, and requirements relating to the Company that are outside of Purchaser’s control, and which the Company is under no obligation and may not be able to satisfy.

 

(e) Accredited Investor. Purchaser is an “accredited investor” within the meaning of Regulation D promulgated under the Securities Act.

 

(f) Experience of Purchaser. Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Preferred Shares, and has so evaluated the merits and risks of such investment. Purchaser is able to bear the economic risk of an investment in the Preferred Shares and, at the present time, is able to afford a complete loss of such investment.

 

(g) No General Solicitation. Purchaser is not purchasing the Preferred Shares as a result of any advertisement, article, notice or other communication regarding the Preferred Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of Purchaser, any other general solicitation or general advertisement.

 

-2-
 

 

4. Miscellaneous.

 

(a) Entire Agreement; Governing Law. This Agreement contains the entire understanding between Purchaser and the Company with respect to the subject matter hereof supersedes any prior understanding and/or written or oral agreements between the parties with respect to such subject matter, including the Original Agreement. This Agreement shall be governed by the laws of the State of Delaware, without regard to the principles of conflicts of laws of Delaware or any other jurisdiction that would result in the application of the laws of any jurisdiction other than Delaware.

 

(b) Arbitration. Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be resolved through binding arbitration administered by the American Arbitration Association (“AAA”). The arbitration shall be conducted by a single, neutral arbitrator selected by mutual agreement of the parties or, if the parties cannot reach an agreement, by AAA under its standard selection procedures. The arbitration shall take place in New York, New York, or such other place as mutually agreed by the parties. Reasonable discovery shall be permitted for the production of documents and the taking of depositions for a reasonable period after the filing of the request for arbitration. All discovery shall be governed by the Federal Rules of Civil Procedure. Any discovery disputes shall be resolved by the arbitrator. Judgment on any arbitration award rendered by the arbitrator may be entered in any court of competent jurisdiction. All fees and expenses of the arbitration shall be borne by the parties equally. However, each party shall bear the expense of its own counsel, experts, witnesses, and preparation and presentation of proof. This arbitration provision shall survive if this Agreement should be adjudged null and void or should be canceled or terminated for any reason.

 

(c) Severability. In case any provision of this Agreement shall be invalid, illegal, or unenforceable, it shall, to the extent practicable, be modified so as to make it valid, legal, and enforceable and to retain as nearly as practicable the intent of the parties, and the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

(d) Amendment; Waiver. Any provision of this Agreement and the obligations of the Company or rights of Purchaser hereunder may be amended or waived if, but only if, such amendment or waiver is in writing and is approved in writing by the Company and Purchaser, whereupon such amendment or waiver shall be binding on the Company and Purchaser.

 

(e) Counterparts; Execution by Electronic Means. This Agreement may be executed in any number of counterparts, and any party may execute any such counterpart, each of which when executed and delivered by facsimile or by electronic scanned copy (including .pdf) exchanged by electronic transmission, shall be deemed to be an original and all of which counterparts taken together shall constitute but one and the same instrument.

 

[Signature pages follow.]

 

-3-
 

 

IN WITNESS WHEREOF, the undersigned party has duly executed this Agreement as of the date first written above.

 

  Company:
   
  TEVOGEN BIO HOLDINGS INC.
     
  By: /s/ Ryan Saadi
  Name: Ryan Saadi
  Title: Chief Executive Officer

 

  Address: 15 Independence Boulevard, Suite 410
    Warren, New Jersey 07059

 

Signature Page to Securities Purchase Agreement

 

 
 

 

IN WITNESS WHEREOF, the undersigned party has duly executed this Securities Purchase Agreement as of the date first written above.

 

  PURCHASER:
   
  The Patel Family, LLP
     
  By: /s/ Manmohan Patel
  Name: Manmohan Patel
  Title: Managing Member

 

  Address: 66 Macculloch Avenue
    Morristown, New Jersey 07960

 

Signature Page to Securities Purchase Agreement

 

 

 

EX-101.SCH 4 lgst-20240327.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 lgst-20240327_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 lgst-20240327_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Common Stock, par value $0.0001 per share Warrants, each exercisable for one share of Common Stock for $11.50 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 lgst-20240327_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 27, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 27, 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-41002
Entity Registrant Name Tevogen Bio Holdings Inc.
Entity Central Index Key 0001860871
Entity Tax Identification Number 85-1284695
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 15 Independence Boulevard
Entity Address, Address Line Two Suite #410
Entity Address, City or Town Warren
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07059
City Area Code 877
Local Phone Number 838-6436
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, par value $0.0001 per share  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol TVGN
Security Exchange Name NASDAQ
Warrants, each exercisable for one share of Common Stock for $11.50 per share  
Title of 12(b) Security Warrants, each exercisable for one share of Common Stock for $11.50 per share
Trading Symbol TVGNW
Security Exchange Name NASDAQ
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 3 25 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://tevogen.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm lgst-20240327.xsd lgst-20240327_def.xml lgst-20240327_lab.xml lgst-20240327_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "LGST", "nsuri": "http://tevogen.com/20240327", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "lgst-20240327.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "lgst-20240327_def.xml" ] }, "labelLink": { "local": [ "lgst-20240327_lab.xml" ] }, "presentationLink": { "local": [ "lgst-20240327_pre.xml" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 28 }, "report": { "R1": { "role": "http://tevogen.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://tevogen.com/role/Cover" ], "auth_ref": [] }, "LGST_CommonStockParValue0.0001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://tevogen.com/20240327", "localname": "CommonStockParValue0.0001PerShareMember", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.0001 per share" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "LGST_WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://tevogen.com/20240327", "localname": "WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants, each exercisable for one share of Common Stock for $11.50 per share" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://tevogen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001493152-24-012650-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-012650-xbrl.zip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

VO2\YY.CWDM/D#>7WM#./AX/-.KWR MQM'8POJ.&G$&>T'6A $/X*:NRC9>AM^>24AA+'UO8 K#1UZ TJ>Q5]@7Z &( M>YO%Y:./LCV\P'QN6O]U$OC' HB ,_$_NB.$Y_K5&Q"NK[YY\_J$8UX8($-@ MB&PSL4J-ND4=2%JZS"5=2=WCN:R@?WH4? M8'S5FP#'V(Z0CJ@SY./H5F$U7SN>2 TRQ-:0^KB?+T4!P4WN=(D-X@)E>^AQ M,28]L0%?+T;,IN64K^-I[!AL"'?@Z--I4F!Y#>PQ<]E:L:-MT1+C,"8^4J?& M56T"[(2\5NQ9I*@D=6\V58?.%6G>3&\+\0%;GLEI1+R4>B**SS-JD 8CNLD3 M:FVA1A%#S9ON%AF%'$!M S'#<"[\E!U3VYX)W[,7"%@:6@'$$# *7G&B2J$7 M6J4< [!L;!-% .]]LX(3U@64H&S.# ?_)\@',%% $:&5QJ&+FJ^R ?F8,2M* M4Y#'?8''VKVAI^9CR[?1TMIVCFX3K+[O=A[!G4?P+^ 1W!;_^A9-]YZ]9\?L M./RP\%$5H^/MO(C;--U[S[6\0I21FI=L,_^@, .,@U#9VO,&CH(GI^B"KI6Q M\RVNVWS\J:T/K9 ?&R\U;3MWC2)_S[:SE:>V\?V=THQU0(F*^+XLSYXAX$U94N*$<$,'?LX]T-[&2P;^Z?$OFSP3 M]C!3O\XD0.<98?=QN-,B?P@HEP_ H1.JQL6N>'1NDE:X2.=Z;7YB% 4T8" MQ^;KH\.#P\.#Z)(16ER"33A+4_Y%33Y%T==&_CQNCUIOM=#52M2-L%R._FV" M9VJ"YY#S\OV64S^*>AK/\9;SRB>F>3\ IV2_])6I/C LK55G:LL7]< <(?0; M>2XWH68;**&SN 8HI3:F6H&'KYQJ+^%P!1:6C8S3G!LJ.P@C3MA$;)BRXM[2 MB*;E 84UB$OF_?16TS2[;2^[FG,3JDMO=VX&K^KO2MVG* 1URE9M1-Z_'%[=J)9+HI8B=0MF6Z#V!S ML4!Y[_322V90J#41Y7["G.J:CX?4M[7MS1/["$*RWP1Y=3B@#&X9-33YVYNH M_93TH165T8F4C]BD6ZO9#,ZY<@A^TX+#:*#P^89/2=:I>A._:,*L^6FVC)T MIS:1JQS*\TKBR/8@-LNVY[ Q6X$>T2) MJA2SMJX;Q(;L,;"-CIC9;C%7>W(NA0?@:UP]^8O&?G;)N SE^6[_MVO"]VXH MO3 NI??.X*F+L'-4BY"U3DGWV0@8G%*_4E#V5 'CLNQZ$^!L6[?>;_R+;$+F MC5BU9LO8FHCF=;7>(E,4".V\4-@*9RIP& .%KP7AO=3%C2X9D;/$EC,N&<%Z$LC MO LZ1\)Y6\*U)!8(H-5$'%G:0/:B7 M5M-G'0U4PCLSB@/J4KF/'KC_9JKB7:7-*S1S)6_ M&4KE!9C@)$I.@)M6;H;+6F6?G^-^?(#(.)/67P#I"/+2T"#"4.!X:6VIA6L&583K#I M^=P/[9NF+[T[?CHJ69/8 MKGS?'UQ6-B,;F:VQQ(9>D$7!D0D/P2(<,SA%; ?")XCWG[M*U ?UH@:[DV4 MMQ]^<\3CP(-*:V5,H&46X$U9C&L8### F%?3G#-<#>J*$;<,604D83UC8=!H ML[UKB,1&H;*#T[#I_QRS8O*E800I7+-#+91T<=X\=/,*V9V.^R@GTE1Q[%RN!-CBML M-&+WXBVV-/[\4N._[Q(+=XF%?X'$PITY_KO,<78S7V@T,IW:Q+YF[U)N5KDH M-BDK>N.M[8BRB3*X MH"TV3I=,X39?*4WF0*ILV.ALIF8,,0-#QVXS4ZPL)H=-/J(&2FR2V7(F46-J MRI-42GHS^7/@I%#J(W)*TLW T^RJRJ[%PSQBYU5.?ILUU@RY9C M414YJ^3- M'+.HD6/6Y"G&Y\0;H2>-=*@GKLX^WND>.]!);C/=YC8_V32BZ5+DTK0=BK7N MK5*EZ2LH4MRL=(C2/)MA#_L>1P.Y3=([@+LF!D/"Z6..M39YHJ_"JT6WD, M6)E[S17X\& TB:V-V]U[T5N\;?:P>>Z.$3S2Z1X[I,KW>?3CLB"2.'&"F3D! M)89X<&)W2B@30$AQYQJNB6^GJ5-P8&JB1BWDAMT7:_Z7/@.@F\-@"7IF!B/. MG^]"6],(=O3]2*>+]'W,B;3J<[\!NE#L:[32Q?LZF5%:Z,(*'Q3$O-J[+^*S MO.>XL,2W(C6[0T"T*:IW2=9UJ":-3/'ZI+W$K6*09+>:\!Q& E8!'F67!*;L MM=K^&;M BSN (;/X%9X)JP]1AM)JO,BJ!!YLR7R995]?)(++.,PGCCOZ_=9 M_V/GL][YK'<^ZZWB"@^00FC VKTJB_HDBX[+14H^/\)LGX],T8"MNVG)K7+> M;.LUA46'F9I"HTB'GQ*UUNW(-G!^1,_.] M7Y:U#)L3O<' Q#)NO)'#P>8[R86(8Z(9W=BXKLS S;<0O<9F#^UKY,!'.JKO MH%O-^]Q!$]3?M&+74U'[AMK?[[ZAH$O*'3U!5=X?Z*7)[JOIQ@R%[H:'8/0V MPG.SMO")4X9(__(GB'+'Y'98B'OWV"U6N)Y<.O(#R)+C-EF"<1.,P@@G'@B4 M4]G@IZPF M,:[,F)K0\WSI5+B^0&[2HGU(TULC\/]45RZ4:4-&L0;%5X*E-2$_[RFGXLA8/+N5WY@48O><&'.CYLNT M2A;IRH:C&Y*#5L=/F-) ;>W.%D.L/#D^=,^6[M[1/KL20&@B;D5NT)%]H,9F MF>:8[;"1"J YM"B5&'E^'(9E_71@]TWO4KD#?<-+GLR&/37Z?&[H$YZ>DWCY MDRC4]'C[(@J-%NFRO*,*G60RP,<:KQ214CANL9[XV*G_/B?W/FR1RG3OD AB MJOSR)4(U/2&JJ0E$X '9M %8%.Z!@;(EK\2$DHD.#!E^@8U+=YBB[FSB4.<+ M*OC@=',$5Z7Q9IBL7_%^O,*^+ES GZFB/T)U;6"%V M/N=G$<69 4VX;6 M:W"CD,NUFC#=]F3EUTMOO/*]3;SO3PY!?+\+0>Q"$+L0 MQ%;I/P_@-OJNYC;B4N,/) %V7J-VKQ$"COA.S,VX=[0G4@?4'02I2&H0@D_6 MK\D[]KF,UK?9H7[1K@(S[+LC%!6&;ISD##.U6*0K[P:WVEU-(6%_%VM-'0ZO MNW3M<6M>TT=<_YY@R1J856%K'KES4;?VPG$>OVM%?=T2[@+$21"!)N,3(VI/ M$83BE[];JXD>1JFQT ]_":WFJ7O<'H"%_[W-\_\+->-!,K_0>3%3F>VK$^EJ MS-S[TB. ]O*+%P >'P1OH+JL<-N/E&SF4_0)@@'ROV# M3 :7=RT'33]\ E:(6HO)G,C.PMS-1KNW?8/<(0\1IDZ9[&A.Z/3G.T;$Q>L6 M7A$R>-DR9YQSIN=H)?LT#P?6.H1GP?<@=_$3MQC/8MF;R*9>U=:TV2!I\R6- M1ZHVLDSBV'6OWBM;K\OW4UNC-YV0H1H(:G0HLXT ML1L%D;XT"!*VB%]APRPJQX)!4V&"YR5[JL1^UP[8&6Z:Y3D<%(6RVH!5O,E5 M00V?3JDS6%Z4^W4OA0FK<[6_S!<4;*<+;]B@"8A:"U<449H8G,6"$X2;-QPC M:\OV^,$Z$]B=8GBN<68W,C)V#S,5<_+.>JD(. M)]7P!>!%)4$4LDM,0.]P!FW,6F:JK&)%[*9/*Q(+:M)2_2&IKN\(F;=31![Q MA(\/_L$@^Q)SADI!A74I*CLH-0E5".K!Y3*S!.\A.&7YN?U4-+RRIK.B.)?- M8DK,YX:#IC\O=%9J 0P#E#]?5(WS(W%B4-E(,H$3AIJ'P0A"C>#H$ &)N0.9 M.3PHF\EMW?#FUB?9Q%%A7S(P8(F@$DV719: 4,0RYK );EAC"M9!#_Q9 &L" M#([RQKD[\+J!"E:W7H"#,&N7X$)GV* VUL6UI&:QS]&):U:@8/U 7"F3'C^E M7H^,*H,O,8&WOO4OL=N5%#LW'MH5UT ,AH(W# O0WI3O!L M4# MG6!Z&)5 'E6)8R<5R>RZ-1JJ/[76EQHQ1&=Y2V'Y:Y7)4CN%2 M=LDCBUX68.N4NM;_H[8*4POJ69:\)(6Q17RYN.3_- #R,;D1!!3%$Z+4 M+PCN@J:PB^[NHKN[Z.ZC9@Q[HWT'KF19;NB(;"W:98]^Z(UL]?>VW6RX=K/3 MRW! K5YVO/EQ3WAOO.\<@1;*?L6!:O]1M Z*95,AT4?H66L?H?@)K>36DC'*]OY<_0JR!UEFM&DL8\&Q<%(U]5BSWG+K M[ZAGFP3)$G$MV:!@A=AC81N/&'X$;1B=1,)1U_X44K/-8_+"NU)\D2"'^0-( M^)8@4U^ ,';A00^^WG4R9<\W/)I)R564)4>=R"):@&:H_:S1CK&>'+S>^)UD MU9&/YHK-\V95PX;BR.'OL*1:'$'KC"F!<>^C;#9@3!9B4G3YM>R8UQM_^[7( M7;1]PP-D3653-N?0YVULE-^X34Z_1RUBZEZL^Y6H MWQUP@ JIA_HM;GN7ID>N4#RTS_([TZ/I)YT!WTR_M-LW-F35[)[76X,!$1@X--0==#%.;"-?1QY=J-&D]M9: M<[71&+]-$ID3@4+\^D"C5[-ZS@ %&+F',<87CT,!:Q-D6 ULD:QVJHRWAO+4 MS[=U$C;.XOO)-+OIBMF"1I7A$*E8WF$L$DS:+C:S/1-^N-@,NA3F^MFM1HK" MDD!4D&?:]+AN\UE9A>_Y(2K E+T0TK0#W[-W"W(#*\9V-Z4#\?7QP>'A<. 5 MX;W2Y]2J6DT%:_VNZ"\&;1,AGF*)VL+I;!;RD932D[\CY/ORTG%DM M+5?G(; 4R9+A2$,7NSA?)^ MV'N?R;/&P@O3=[98%WK\I'V?DSOAA-0^!HH93('VX*1^7"?+'OI![YS4HI)" M)B21=E$"5^YHS\SY@-RN(!B<]_2XLU5/W'5A[#4C1'YO\LUJZ5)7=+(Q[;'L M6(EM.@^/FO8?W@YXX?T-AL;.,^QM2;Q:F*--*B0^OM-AMV?"#Z?#LJ[J=OCP[CP\-#T'!CAIQ!YO? M;2$D$G]/7P@3/FBS("D=59J03XFFOB03Z&B7";3+!-IE CUNQF MS-94_+[" MX\I4UX>E0WMBG4CAA<<-?)ZJ>T M($^/ B86]C&@HF M&ZUVKM1'/N$]#02'WA>14&1(" A%%+81U,,\]N+,B#=.5'(]OEJ:Y3BH91A/ MIKF1GBT6QPPH(,X2IHSOB(>#ZP1&:TP@:L(I.YD6\F/I.]!;G^U&,IKSJCA( MO=VMX)\:=3^ 1XD[AEPZ\D0GO""AEV#?K7P'O0^4PB7Z-8A(<+?G=1.JHZI1 MA :!I\!W-AM-/-1TJY*5I=1&RCDCZB>CE_]ST2U'@N'X>0X_'!S[5@J<;MB< M2OO1%X<N'E>9E%6. ,-49 M-P KJR)?4:(D_1CJ+G M&=!LLS)^II*LK&Q-5C*/9-,Y0O.PE]1OS5D6+UVM/K7^U@BL [,H*<5A6KD9 M+ET237UI]G\?W[57"D,C%I"O+A/4:Z$^JS?HX"IZSID!<:]DBUW"S==NK['* MCGK&P0'3JO"8LSU4Y3*.\]N,:1!K^VN@>C[Y@FRK>@"N1RPXFF6_7UC5K0HO M,7!EH@QXD+@ UQHW".F*$I!'>4ZP><6J*:66F7W4AEWQN.^AK:$?:8.B7:]$ MWV)1]N3C"'6 :HG2R"B67*C,X[J)5/K M@VB3=O5S;X[W<$!, 0D9J%*D]GV!"M:4AI0N;R"R*]D[UD%"(T=FB>TET;-"6 M3-]8!'B[\5' )FB;\\Y=8#->9$;1STR[<:V O^]$,D^1"H9 7+1E+31:94?; MC$NZZG]&4T!@@622J+!-GUK"OB@*?)#.B\Q?(/"-T2-$K A_*71%[V*L(,N: MB&VS^A%C$(M9M*F,*1 %Z+U.JFO7(< /,.L>(38Y$!DJ>-5-7AGP!:[J,3QH M!F^JM&O)NQF&K@>+].(J#JJ:"E[:DII8 ;UQ/,F2T8(@BU:PK,*H.;)72,1 MHMG#-C.W'6O['=/]![.V?RK,'S/I,2Q8,=[OV(;#820XM"2+(Z&D\,&*HT5^ M2WQK072$L>Y28"TRFEI/]9_%5*Z_RU+XK2)P*>JS",QD2B(:U5+A=L0#U4/1 MANFA-4\903<>*@PK]E@M' Z <^B&)H$LEJ&N_++4FJB#-6I[MI@ZTI8EB>MK MLCM;CW2ZWQ^(FA2C&&"O4E-1XB@'C1+4:ZO*R^40&9J 3R7((ZH0QO5BG$M MBF20$1TVW'&;01"3KRE)42Z#851Q5K]&*\H!M>+W\-@I3D!-)@5J.2E6@B(6 M8&:M0,YO;L/I9S C'BGF16-55Y%GR9@U@#GH!09V&L$;TR1$9*ROBHY.?WK[ M+A8*!I6EL%^$>L&ZHEV(27L>E;/-V\^G/[K-?[CYZM?WKW^?U!+ P04 M " #.2H)8=*IG6.$; ! ]@ "P &9OLUT:U*/7;MV[7?M'/[OL&>2!^8(;EN??R_FM=\)LW3;X%;G\^_UFT:S^?O_ MUC*'71>:05-+?,YV7;>_7R@,!H/\H)RWG4ZAN+>W5QABFZQJM#],;%?2M&+A M[_.S&[W+>C3'+>%22V=A)Y-;][/'Q[=ATY9C\EA3?!),4BY,#0UOC7&':./M M@GH9:^HF-JVJIF[0E N[4BKN/ :':A%V&,YJ6T28887L[Z/KLW%S-[G]N&G! M=:@EVK;3HRYL(8Y4S6FE7&D[,DA.,#TV$/R>[]@/3XZSFRL7@W&F-B>^4GS= MHB+$N,$FT!W,"2^@1ZD<-'18>^:PVP5X&S3T1*Y#:3]LW*:B)1OZ+V*CPC/' M-IE(;"W?Q)H;KI-S1WTFDD&!UP5\C7U*.:T<08MN>Y;KC)+7ZK^,324<=QHH M>!AK=/;EYC9LY;('N\.LO&[WL%%%*Y=VLG@H&35J&8)_#EWNFJQV6%#_9@Y[ MS*4$^^?83X\_?,XV;,MEEIN[A65DB:Y^^YQUV= MR)-;@%X%->3A_^1RY)0S MT]@G-\P](!>TQ_;)T!@>D.:Q_.%.*S7NOMU\*AU_J=>OX!^$GN1RX MQ+O(TNZ"I=GI![^K>'0-B!-CAOWJ/60;\[YZ:M'/7IJ9@SQBI&!FI MX3D.CL.%3LWOC#HGEG%,77:G7I_=:,-SKOUS_M_/GY\QPTEDAA,+=GG4@$D< M:C8M@PV_LM&=!LQU=UO;W2G./^SV$>SA\5WQSN=3:GQX](PA2GHP<5>Z MDUQ9C2'DLV<,@Q04; MD&N[1ZTM]6 +YG=X&\^.P1^";@87?9..]HEE6PS?\>$^G@/FP.&2OW##8!:> M-/P-6EUX/1A'5Z=HZ%XC!ZN+RS;2('('.)[$@D7"V(SOQT@K2[CQ.=,YRMI;+%4O P-*:-9$:HU-6LK4Q;2;-6HCB&&$ MIL]@)3H3\CV*EGTA=0: A4A%8+\KY8;9$6XN./KYH3"R_FODUI^S@O?Z)D/6 MYD\3&UE-)6S/\6>"1I+,]OV5RT5,K-QGN$%+)E3G.G9O/,'XISO=$RY(@H;=Z]G6C6OK]U?4^9.:'M/RB*:\SUZ,$*K'S_TW!D R[)M& M2050F%QL?,P%I(!/87(ZB_J /JK2M.J-X]&3)'YX*V M3'9J.Y<6D^B\;$ ZK^2K- M/C0)A@I>Q<;'L9('5]K1K/']Q!U=_B0:?<5BK$6 MR60.^\_54P\(TEF.FKQC[1,=C@=S#DB/.AUNY5R[OT]@B/!!RW:!U'!1P0[,L^+"6JT%][)LM= MT8ZTEJ):]1Q@'I !-]PNSJ1]RL9ZMVP'L*=Z'YE4OR<5P):P36X<$/]E,))Z M#^QHW"*ZBE>@8VKUN)7^WQ$<%&)(>.N=5EOR<8CK!2M10$KHQO\G+3 EV'W#0O+U9R>25_>7]1T>56Q[6MK&5\:UH9F.H1=2+)/+:U*L;AB;Q&X3M\OPE>=PE\/P)T.] M2RU0->JZBZ^+>^7*:N-@U4D2[<8,[,0UZ]N.2S;P=]P91L%*8,(E[ 'F)(Y\ MS8S-?0*+GN1ZE0FN=R4-SR!TD,C^!N[%Q=^W5V[OQ]ZSV)\*\B&K<_<-= M MVZY!1R, F%E)[#$&3)1/%K.U<^KH75+:V2(XQZ_$,N>W@A3,U'/MT.0I59^T M>%;;@O_MCK M7%5>J-TES17E7J5L[5;%GS-'W"9_V":FO0C2M/3\AV-D&R=#JKL9Q X*)R?$ M"J&"B#[3T>ML$ Z;Y@H".@;(*F=S-=>Z9MIKIKTT3-O%0 K,99KP5,>\NJR6 ME;_WJ6$$OS][?1'7:>@1U6W3I'T!X 0_23?^H>L\?_P'YKANN+ M^3QQ%-&V,0T/@U,NZSOV W+BN+H]!VQ1\54&TX.9= !:^SS2RC5>L7=)ON* M*7Y:X EZ%=#O2G!',8([Y2:#S6DQ)YFZ1-74!][HK]$?+W5E3 X7!I?>QJBN(O&ZFNBPVQ)Z'I6=4>,E=9ZVK(SL(Y$X)AQQ(3X.E:)TEO K M[KHFT!4GT.;US;,X\$FO;]HC3)3[$.03M;*U8E M9O$^1)_!7Y;.R)'MF>R!.L8,[7F+S(H*SIJUE+S,5H6/FMP\+]Z^SBI(F#"Z MS)UL[<;C+B/_ LORX]B5R=[C1<$.YV>QHGH5;+!%LHKMI#/4@!\OG5M[8"6? M(*WZ]>?/X\K@WC;3.$'CZ:+G!PXGYMTS:Q8_4%B>6,].TGJD-7CI7#GV ]A M,UR87WK#[S>=(W[T_<=B79C)0$67OI>MX:;^ASF"C=Z!=:R4=KS(TU%-HJ8K M&[;8_#_>G^T.WSWI7P-)E\[^2N-\Q":,T$E%R]:T':VZ]X'\3>F9'S[R)'QV MF_0=.&6\3TW"ADSW7/Z D5Y0SYG87 7J7)USM &4*F%#C9+N_BF7?WHMDR-U4^80JD0AL(8V4?G1(#10Z20F M%4'N[8IF,[U=)N /3[B\/4H3^$:7Z?<9S&&G?3 90$?![.B6/20M9MH#W"]\ MB;M*=G-?29N;R->Y ";OHN/$(*X-6]GS3)=:S/:$.2*"NERT1[*GW\%NP1*D M'S+(F8]DN'DPCI.AUBAXU[9-F!S[H1G#,<0@]A>#X;4_\FW]D5J^5.56JIQU M0CR7?/'\E\-=(%&,4GF6[P07R3*:5AZZNR>7GGWY/!D=3=5OV;;)J"4KQD2E M=R(841%>1L+9VZE4#IZ2X*FIW M@)/XR)7QZ;*VD[U^B04Z!.9"D4JJJ,S]Y M>0;OS&P4=TCC])J4REH>&FZ2I34@5\&X6L!.+[D+A8%WK8F? M]_J[7+L_S;;G*VSV M^I2C=/.E;K'D>!"$9E3O$AV+3*;#&/U-#7$BL;%4EXS>:-.*N^ENFD.-P.R] M&?5:MKF15I; >LN"VV3;J:X+RQ?$CAD+I#%P]T&7PY.Q"%B8RIG(N)8E,2,A MP:D>N-24H!P52RW)L!+5SCN_7BXTGU4P]\ZO*9S+S5FB^>Z?!T_O.'M_=GYT M]$=UV;3*8D>=>!.KCJJV.]F:&E$Q 1QV"PZO0QYP9/*;&IOTL9!Q]WTN&:^" MU?@F5!PD@OML6W'L-R3ATM[QZ>C\=N_G_?U;DW!LR5'ZW04I]N>7BS59/N$> M>+/,D]LN2\Q8GF3!@14YL_;/8FBXZU6^[ABMIFZ]#0E/IDVCN)[.F$Y"2I3* M,5.:"H/^G$'GBG&3<^K<,Y>(C5VU92 XX4I :D4SK_[Y\SZ)BY%]>KL M9_M5Q)G.AP[F4R"JFKJ_@/.IJPJ^5AI.BT> 8.*FU!]0;U5S^S2+;W^3\Z^5 MC*7CY@F>W)25CY2.3K5[W+L>'&\_C%ZG7:=^=&8I+M6B4ES^6M/ZDM#Z3,UE M4FZDJ[FD= !NM=VOVSM7/QM_TF4X *FH/=52VFK/.@2QJ!!$TS(PB,0RK1'1 M,=T7X;@G@RZ3U68F1V? MNG+0!4[&3*:[P,DL6P9B/<%D*UB ?[$!/[G,97!6?6=,6D0XESE"TA]PF!J) MW@+PX8W#'KB ?L ?J:5CGB+5Y1>&$5+\WK5!'4.H*PW&K"AP>8.&4> HX\M/ M':WXU>"3X6T(KJH'/^.C'/7*J-UN_M-P4L_;F 5(]%#-GY>Z6G2Y+)_ABD7) M$N-HD0]U15?Q8>H?CS=W]4DH1D.(N0/H_=/#-"'H)=$HS:)IDG@D=OH4R6U+ M4ACG<43S-B;S.N*33B=D3"1N3%MX8V]G@@\SCG*3M66/T'R-#9V@[00(#<9AT)>07]_F! M5=G7A7-)Y1"JBTP?U2UUW]3@0C=M4+VV,-7BE+4/]EB^*!YN!)@AC M/C#A@BH8[=?T'P:MMV**GTH,P>9!NQ .@U0U3;G=!:J$B!(TK%P87U0M*2?_[=27B.P 28H:7ER:9'X9X+B& /% M-0Y@'(46J?>4P@P-,]=,EA\RH@;\53!_B+E9..A31_:@XQ%!K?9'Q ;3FS - MGMP^ S_9%2Y\.Q&1N>(,5)+GH'([@LJ%*K%K'A DQP&QS[6; ]@6TF)HV4CU M E4:_]R[M@M4!-V!-+:T&'E$"" HEKC(4366T9?P^7=L$+2A/ M;J7[ZDF@A-?Z 0,0"0XH/J;26WS[$&W&*"5*^U6^A_:R-3Y1\"CS-O-@FV!+ MD0'#9GAX8,VH882DBCUB"T'RQH&3=;8XZ MIPTS!\N7N>W2W(Y!_A22,P&2P<#,/=AH@6\IQ' 6(P#'8+T^ M K,E>8ELIE/'&$$KU$]&]GF=2N1#UN6G+D*5N !<"X6N-2.F3BK'B MI]JV2,MS,XJU<0NG5-^9 R296 )*!QY%BC N8@YGZ:E%A5S7%+;/RA#/J+X3 MT\::.L)WD,ZD,,"[[;G2XX +ST3I2*X.=A+1X7:AF1QLH&YOXT$1(:SF,/.8X2EM*Q<.-(G5"\>Q M6B.3#K#V!!P9V$%+EA9YP"IU2+6/@[9V""^>*S].E"TF/6% 5&H'I8.-*L<7 M&^(A)&W'[L49A+K=$OC'*AMTY]3JVP?*+4^@B3#B03>6\4E!1R AD$W5T-)A*UCD!;5[SN.#8< O2NVLX_*LLN6O=36TBSNTLKX MILUNDFF#"H>R'AIQR7/,!,!*@X)%C_"UJ*D7:18?+Q,9+[ #%<_!WL%GHI"= M.]'H.]VARYY:>]WN>[9ZRA7TBXK'B2]I)?AM2H?UMJN?'J#J[!XY"6HB4SF MT:LMRY@HO9Q[NIQ0K7HEAZ4A%&!3U]2ZEW8]@B.5"(?A%X*E:TA)?.DDL/V_ M V\%C&J@7<5;GBPIL!5Q?0@IX_MTI+1DKV\K$\?D/SUN4.4=@=Y@O,G.OJ?$ M"B^I>OT)"RX%B>Z^_6T(]<#L)L_YE&"DS-.E@$-AO0Y_M&GM"AI(BG!.T(2#H\IUMN;.KP+UMZ(,&DGX M0BWU<4?!FC&M/%1KQI0>8SKV%8(U(WH5J'^H"%U0=^0Q_R P*!GW,%7-=H?I M+!K+%)BM['BH11D48$&]C$:#GBTJN$ 307JGJ MOVWP(@SF^YZ[Z*>2',IX9 MY8Q6/'LC(HFV@MHH.(J,3E+/A;5+RC5'0825!?%5&9;& *N*BL[R1XZ+9L!* M>Y1;L9@HQF:?%95]*IXOH[4R>P4_\>/*%5-5N8.*G)]_ %T4$C'Z96'DN0/( M=3#L@(HR.DG'N]&G7.Y3) 8+:PVN5Z7X!8")&B-K.;7R4*WE5(K.EM!%LI94 MBW9H8+@G2(I*<&!,IS\],I8J7B"U]+ROJ =H2FU)8_G6-STA67H]D*''<;'J M"R04.YZE6#NF2&&,2WG-YDK>FBK/@ _= 0BPT1,)7 U$V85,X)* /)'$11:5 MQ!5=P2\@:5+_5NTORCR67. L:09,0ZJ=(OCX^[Q_KJ5?=C(;1&)G&1XM?&8@.W1D*M ">NS<=2!G$@K$6\#S Z)P=MQ'&(B&I8@Z\*2%YF$"V3I7<;LSYQ@ZI;J MY W#T@&Y5-'!?9S.S\$\(+*H&KQ>7T"<<0$Q+(4306Z U@-R.^K#_'6'MKA^ M0+"RBD+]A8T(+<6N" :]Y+WAU;K)N"A:7F='S;..]+.C&NIN0&:&BO"Q\Z02 MTP/'R5-I@EU7WMR7W?6(9;>^ZJY'X%)^X7T/,M=]CXGWWHA+JH068DA2:L6\3I$#CC:@&N^ M_2I0FU;H6U(Q?TPR?9DW1SF"E*MHVDT45\)YA)D"$VYS1R@;JD]'3RGW@8C! M>^@]K"07B=# F'BI2K'U()8#8&[PS9FY%BI.%<2H)!13<:IHC KOY=) ^CR5 M7V(9,#=,+N75%+@@/0:V9QI*Z+48&"!^*HD2IM20F<=S24_9>YQ3(;V*L= 8 M[\'&X,5>V!.2LE]:([$OB")BO/@(02_DZU8:>2>5OJQ;G7 M16Z?.%2R>,%>7BN2T[":;%BR7EV?.1EV>8N[XJV+$JS*-J6\(X>\MF%L9B)8 MY[75K??W03[3.NL#VQ-!R-9KOB I3;,'3B:;]CZP]EO/%M5KX*^:X+C/#%96S@[2U[L#M@61]QF^"]$I " D-R(.IH[>.;,D5M M38WI4&-1"\@Q4AF6S%L9UI"-J'0"39:E;2ECAO8P.#Z37F4;O+4C:[B14[FB M+7)V=O6K4')E3+^NVWZY.W8\ZJ>: MNMCG^VJFG0:+O;KZV+1/7FBM1"ZTGE'AKIU5"W!655[HK)KO/NG;D-VBW1O* MI;H(SUBA91LCO%S>=7MF[?\!4$L#!!0 ( ,Y*@ECLD!M0V0, 8/ 1 M ;&=S="TR,#(T,#,R-RYXP$-LN1(,I#[];?R"P$,%&AS?))WGV=?I-5J:7U81IS,06DF M1=NI>A6'@ ADR,2D[7P9NG\-KWH]AWQX__MO!'^M/UR77#/@89-T9.#VQ%B^ M(Y]I!$W2!0&*&JG>D:^4)U8BKQD'1:YD%',P@(K,4Y-<>+7JB+CN$7:_@@BE M^G+76]F=&A/KIN\O%@M/R#E=2#737B"CXPP.#36)7EFK+"OY[SCZ@.E@16Y< M#F+]9GG''B<@WB8=*A;Z@3Y]ZHYN&_]>?'M[!;/I_.'OQNB!/_G/BWE\.9UW MV-,_HO^I.WLDFOBU2J7J/P[ZPQ3G9,#F MDC,QVP6O-AH-/]46T!)R.5*\,%WWK7I$-:PLHY8=P#.A#17!!CXT*\(Z^,+/ ME!M0MA-ZF4%9 0UA"ZB20X1"',M5=2!,4TX9O"44,[&#$*'&*HF8&QUZI@&<-A84>%4"(D7 M 6]C+K&R.&98Z2L!BFQE-)7D<(_1$[O F[C3@]7Y5Q*;B4-8V':RY9JMPEH( M8R98ZCF_>%7BVFN6V"1QF3);_C:X;"G1$-Z(]^DZ5J"1GF;41T'.SR&'N0'E M0<+/HK[$=XB9RXM]+&UP]NTQ=)V-+.=T\EE4P7CML,GVKC%<7[' MM#VLHP)B/1RXM^D9;>]4[K@P0550LE+J*VA$QJ ,PVNPUCRRT)FQ]-LU-\3Z MT0[Q?V'FG(Y.S1PIP%\QY;ZU_QJY8I6=FNMF8;Y2PIV5DW+6+7^SG>#W=LMI M8>)2&2)*K>O0DY,]EGT9I*8.4.R76_!<*W*K->R\WE*'+Y&>$L3+-IP61,$[ M(X@]#]\N_WH?W"YL,=6/=;KG 3WH="?'!VYT(3D[A/7G]B=B2,V<%,2/W_!] MX?R(F7[KLXH@D(DPZOF40EBG%!_GG<;+H'3<013X[!#L['2NVS.JH.Q\;PGD M(U8ZN=B)[#O^:8FD&!H9S&ZI2L?]BF=GE5M0PRE5,(!H9&<=&[6==HZ%,X[/ MD&V>1B6VG]I1NXE]ELGP/GT.PD2E6>%@EWT7HV4SE!%EHF<@LDCJ%!5&?Z3!].,25,"TC0D'S!L!:;@WX[6,4%ZM>A>5 MW:G_*F/_[\:T_*R&&ULU5U=4^,X%GW?JOT/WNQSR%>SL\TT.Y5. M0U=JZ Y+F.[=?:$46TE4*!(ER9#\^Y7\$>Q8UW88$#8/D-CW2N>>(TNZMF0^ M_;;=4.\1"TDX.^\,3OH=#S.?!X2MSCM_S+OC^60Z[7A2(18@RAD^[S#>^>U? M?_V+IW\^_:W;]2X)IL&9]X7[W2E;\E^][VB#S[ROF&&!%!>_>C\0#T]/3">./ MZ(F+>WGB\TV] N<*J5#N2^MO^\E/[/Z)$G9_9GXMD,2>YHO)LZTDYQU3;U+M MT^B$BU5OV.\/>O_Y=C7WUWB#NH09WGS<2;U,*3:_P<>/'WO1V=2T8+E=")K6 M,>JE.F9OUKH?:T*/_(59D;:GCG7FW#==#70R&LM M\/*\0U=2Z<*''_JCX2^FZ+_GC-3N03=A24P+['B]7+5(^&G--N-L+4"0*=]'2".:NIN\&9AY#X*;M[U[;$B2H]#&#F\/2[&U?A8:*F/TS:)ERBDZL6- M,G7/8]:'"2.FG[O27W.X\5;I80<'*7)38,UN21%E;),Q9>!US0 4:BA*?XPM M$Q0I#LK]7.74]+Y<%%F3:;A+)!=1S*'LKA!ZT/P-1SU,E4R/F"YQ%+&8'+@S MPQXV,'2P>*H_RK0"BA:81M7>)<8VV][[HKY%B^>&5((XL3M$^ZSU6*2XDX92 M\VJ,6^>9SYG2K>."1K7I%HY7YD.*;"GXII+*A#9>&D&66PVDXW$18*'G;/UG M+)1+')QWE @M(3L6:$*1E+/E7''_?KPE=5I7T>559;,.I54RY=D')()BM:CU M7KID(7Y)!F5($)OMJRI1G!]4R0 RS"N10U(,^^W4XFY@ ?Y:\WT"L_7P6T*+D6^,N" #NUE_9J@"P_D1"(*7F!_/7%5O?91)I>^)*+&<,1 MJ-DR@UL?'PQ.3ONU1'N5LN]L?4=C)'V]$,&N\U6&,8G]DQ5_[ 68Q+VF_O#< M6>HO=^E,^5:7:-%3FV0M[CZ\CRK54SH;4(C;5QF5JJD=:S"! 71)T06D;[I_.L(=K]@Z0ORH#)S38#DC&4[N#X$#'86;ON*&[PB4HGH?N4^H/+. MP^K2:!&JD8-3*+=JC!D+$;W!#UQ4B)"U; 7W!< 0Y1_<4O[O$ F%!=W58?W MN!7$VS!#W)\ZGJCHB9>,J*I#_J%U*]BW@H;H_X=;^N=K3*EYO(A8K=9?M&^% M! !L2(1?WD^$BTQ9QV1,*E[1?$NDC&N.[U,=LCQXR@13,6T&_'?6K MWZ'[4Q+\%R-16X"]<8OHSV,&R7>4 4]"(7+02GL>R+K1])>"!OEWE/->,$74 MSJQQ^QX"=Z"UV:%5H_FV@@5Y=I3HQJ#26Q],F65\95SG+5O MP4PR+FC!#<& M-M'P!:)3%N#M[WA71OJ!:0M8MR$&:7>4V,;(K@79(+&;$[^Z8SFT;0'Q5L@@ M\XZRV1C:+=I. QT$69)X!6RU (!+"W0H0P[*X2B=C1%.F<_% \_<[Y[P4%^U MNPD/2H> 4L<62%.-'Q3(4S49M\>_HNP014<9\B'5HWFV H6Y-E5NFHV M]$FP>]B?;C2S>900I2_>-'$DI3\%41J/65D>LN0.$O#DSVK::*IAQ"#MCE+. M.:?$UPRQU3<=AR"(VCDOVC6:< NR+:C[/):8-,&L)[D1XOAS*Y@,5LNH9X: MMF\T^Q6P014?8#W5'N1L,%[=FVSO0 M$QU8-9IW*UB09T=IYG=^*Y!Y1\]\MUEP"F_AL1@VFFT(+TBXHXPRA\I.=$6'S;+19(. 0Q#N"$A;#&]A1#Q?BWSYC>QB5!=Z@]V M":RFC28?1@S2[FHK;!@0A8,8X"5AB/DZF=L'!=PAJ/)JMAAUP(.Z.'U.^A-3 M^COC3VR.D>0,!W%B4?:T G!IM"+5R$$YG#XY_<%IR!02T9); 5P;5M,6T&]# M#-+N]"%ILJQ\/W+%KP0M8]_NT0(12H"#6CA]>#IE"@OD*_*(OR"%$KQE6M@] M6J!%"7!0"Z<+CZ,+=:+C6?'RM0,YPQ8P7\0+$NYTO?%\@RC]'$H=@"SM?W*& M+2"\B!)= MC:4J%*S;(($=-,3_J>-MLV/?-TM-XCD!"Y %(#M&ZU!!6Q0!4=I\DRMLG:7+V-0^EPW+&KM'< W!!MIUFP=?A@A+_DG)4 M.N_/F+6 ZT.T(-5.,]_/B-V+\$'YNVO!?8S-@R&YOR9K)%^U"FB!//7C (5S MNQ7W^06>T5L[Y2Q4T7]IT6A+;UR4^+5 IDKXH#J.7T4EG[?LX>#S[@8OL3"+ M-V[Q5GW6%=V73ZXJW1NMU7%1@))E4N]/O8, =?7W^EQRW/PR_U9&'_D_4$L# M!!0 ( ,Y*@EA85YQG$PP +B0 5 ;&=S="TR,#(T,#,R-U]L86(N M>&ULS9WO;]NX&SL-C37WB%-DR*X-,GBM-U6# 4MTXX0 MF30H.7'^^_&')$L4'TG)Y4CV1>N*WX?Z4OR(I'Z0>OOK=I6@!\+3F-%W@_'^ MP0 1&K%Y3)?O!I^GP^/IR?GY *49IG.<,$K>#2@;_/K+G_^$Q)^W?QD.T5E, MDOD1^L"BX3E=L)_1)5Z1(_214,)QQOC/Z M.-G(+.XL3PM$)6ZT3DA&1H'=\ MA'[:GXQG:#CLD>\70N>,?[XY+_.]R[)U>C0:/3X^[E/V@!\9OT_W([;JE^$T MP]DF+7,[V![D?W3XVR2F]T?RKQE."1+'BZ9'VS1^-Y#[S7?[>+C/^'(T.3@8 MC_[]Z6(:W9$5'L94'K>(#(HHF8LM;OSFS9N12BVD#>5VQI-B'X>CPDZ9LTB- M6_05)VE\E"I[%RS"F:KVSMT@4"'_-RQD0[EI.)X,#\?[VW0^* Z^.H*<)>2& M+) JYE'VM!8HI;$D89!ON^-D83>3<#Z2\2-*EC@C<[FC-W)'XW_('?TUWWR! M9R09(*D4?(#E>E/+*P\:N39[37C,YJ?T9:[-:$_VQ;G#L]]1@&J\\R+/-LLN>4>6YP.E,9;Q)ATN,UV(' MD\,12;*TV#*46]1!R#=\EWTC61&:G20X3:\6TXQ%]\?;."WVHPKY;M!#/S(+ M("./>5$*S*..0Y$K1A$3'=DZ&R;ZH.OP!6>K7C;R8\9ZB+\GLS)_?9"%!: @ M-1DG*=OPB#RKCJNEZ7M4K1$3( 1NAP\_3P2]*AM@"*2'Z)J7_>SO:9?T2 MEI)E*L^5R=\/#B?_5)!?A>#N16C:D?7F*LQU,&^&#R-10,_O<.%&R9X7Z@*=EQ1&4O2<..] O>89NDICNY.MX1'<8IG"3EC_(H29?]J42FAV#X>[_]TT$WC*V7LC-57 M/1 ER:^2:QB;TS MY?5Z^5M9@JY.*!=YZ<]K!JV=N%)X![#5E@E3*4+?E.QW=]6O!X08OI)S\;-S MO%<1>@&C8=0*1ZD*#Q#36@LD4HJ4]G5)24FTOV0/HSF)-23BQXX-\9_O'UBT M432+'(T"-9-=< "9DK5OIGFO<\"06=.%!$F-XPH^%CN>RYV?)7AIL6^DNZIB MJZVBCFN)052RS9%9RZ4&29&O:OY THC':WD;N*T<-9GS2K>8;-1]11,6 DUC M, D5K:>&_88LXS3CZKE V>.T-&. WG73WVK;[ NLXB"@Z>,0["VJ0:B,\L31 M,:4;G-R0->-M^-1EKJFQF31AJ6J"8L1B#$1#:Y$6>R+B7QO,,\*3ITXH&DK7 M7 !6330,65!TV+V!@)1ROXS<@"K)C>&+"AB[-Y M5K0<*;U_2$[IO!6AE4[*J4L0%!,;UV8 M2+T72$XVG-=8:[TQI>0T43SW0*(I P.*;,+0%VDW4* MZIJ 2+ : VC8:=5<)"]$G(B6B>/DG,[)]C?R!):KH7/+!&"S#H4A"H@*NS, MBUR,E!H)N1Y); MO#V?"U#C1:SG$790 NK=PM)AN\X,( X(G7:' $$B"-6C?()T3B/&UZSRNL,) MVX@&\.F$S>$12D>46ZAZ%:&.5FM(0(#U\0E@5@O=T^^D(";G?ZL,D,S!"W'' M\[DX4&G^ST5,R1@LOU7KEJX6NW6F+,* 2(+= ?SDRKWB!Y(QZ(J& LWD&46= M^(=FTA>:2=#03%X"S>TC"P2:PV<4]= _-(=]H3D,&IK#%T$C*MYK6W,B?E[Q M6_9H>SD;5'I!IFG5"LQ.%AXN#6]=L,@ .9Z1(3XQ40.K*W[-V4-,(WC(#,F] M .8ME)C:,-#QVZPBY]R0%S$>6UK]*"\\R0I9'Y:F;I)>Q.C->%!4C?6V;AH MM4\DKEF:X>2_\;KU0MPN]H*'U; 5DIHR/%1L]KJ T3%(!/FXL,YQE0\TK%/) MC'1G3YMMMLI'S-7$(""P.6HNP*'OGFB1ZVJ6C'*"@1:AGNRLDBVFRCJNI(51 MQ4U#C1I6Y[70^#B1Y:J R?4=H_ + DV)JYJ&S!6U;:8'4>. *;/6E0PIG:>[ M\7)ELM3>?%?2G/7LIIVR(R\2@JA=TTVCFR[2'=?F5QYG8L]R\9D-S9_RV-X; M!'2N:KG59E'C5E$0M=_FK+%FD-:BNM@Q%E.6Q%&<2 B)J @U"5 N2,FO%@MK;]\F=@5%M^$" M#E@9!"2=]DQ81, PJD0@'8)4C%]LSM-T0_BSX+&$>$((- ^ U-"'B!-DLA,J M'>B3K2F)-J)_?!I/9K=QUEB$SBYQUBR4@/@@W E,F"2I/+%(XG/\[^ MAHHHQ]5_R6XYEA\=F#ZM9BP!5I^RJEQ!T&*QX, B"0(%V)=)PR5#N11IK8_5 MJ6IF+<4QTET!8+555'TM,8A*MSEJG/RUNO;4Y)]NHSMAB@ 3$NPRUTV_S:39 M_%W2U2R)EQA8G+!5[1J*%LLF'Q9I4*C _L VHPQ!NQC7*UJJ)<[D9YWX M2NW_3/RPE!+0.5O3LLUFN:BE310$(VW.&LM:ZD7G*F(DU:ZYV,SCC,RUF;.8 M8AK%."F71[3=$>\.<49+3_,E.!WZ,!CJ9[*!DPXKUC(L W=+7;J^E:Y?P/A* MDN0WRA[IE."443+7]U)L3XK:]6[?F.FP77]I!A '@5,?A\"K,S)H>"^C4!&6 MWPGS0M(7EFQHAKF:2\YM+1.@IEAFA.,HBQ_(!YSA MW!M87DCN>E)EFVES-J5-&Q!"K0;!^9-EC%PJ!A=,>5LRAI^(H=:2M;PE;JC< M+QS3L-A<.Z:4!(2'S5?+"C(<%5HO+$Q7.$G>;]*8DA3NB R56Q:L%NLLU"0! ML6#S!;"@I*C0>F'A=$7X4G1O'SE[S.[R]5G!L@%JMVRT6JXS8I4&Q$J;/X"9 M(@3IF&))73_P;'<+BNM5%N&26J2.L0'-&LPT="$! YEKT)*02-YON609NF7H M^/=)0!@%2 MISWX.R1E!"I"'%-S)1CFU>LX94)^2P^<[= =XHJ@ON8+CKKT0=#4TZ3)E JK M7URK0/5=1)^K&547MX>'>#61XY&QQ: Q,*XH@F $M 4-BZO?"O"S=MYFEL31 M6<(P?)>EIG&\8E[3GK%8WDX0$ %-5] 2>4J(E-)+_;_'])YOUEGT=,U91(A\ MRRHM6ZNN^V\]H]TR\ZPBU6GJ%1H09\_Q"Q"XRP)5\MBK]%@^;^95/GNNOG6> M7FVR5/:@PAA\%[PUR/'CA1X%,!XRM$0$A%X/F] #A\IGYO>0#D:5:$_79^EN M%4 R?_]T0Q:$RWD'MV2;O1<[NF^YPN@1Z_KJK7=QS(NYSL @('RN6^A2+T75 M#-!,OB.69X&^R4R0RL7V_?+JI@OQ2VPN-HF_9C@E8LO_ 5!+ P04 " #. M2H)8$>-9VE4( !M8P %0 &QGCDMFP='IA; ?C\+@E@2H-_]NE[RZ)DJS:2X;G1;G49$12P3)N;7C=\G MS9O)8#1J1-H0D1 N!;UN"-GX]1]__4MD_[W[H=F,AHSRY"KZ(./F2,SD+]%G MLJ17T4&VB^V#5]%;UJ][C1J-@'U?J$B MD>KWA]&^WH4Q*WW5;K^\O+2$?"8O4CWI5BR7L HGAIA4[VOKK#N[?]OB[S@3 M3U?NQY1H&EE>0E^M-;MNN'9WS;[T6U+-V[U.I]O^UZ>[2;R@2])DPG&+:2,O MY6HI*]=]^_9M._LV-RU8KJ>*YVWTV[D[^YKMMRQ@?^")9E\U^M[7622.'GQ%4DM,'.HO<_S9Z^U8-?99S*ER\VNZ[ M]D#:_F@=S4HM%)U=-_A<&UMY[\=.O_>3J_IO1T9FL[+]4C/7K1I1^ZC9E:*: M"I,IO;,'CHK0M;&]B29Y1:Y]H&.&&6>[ZRK=J.GZ5;JT3=F/6\N='[DG7,9' MC7/'7YXHS?MR1EG3N#67S^V$,DN[UW?5Q=^";.\>H@_-(IBY&!4=W MAJ=VI]X>1O-&'7M.5)Q7;#\>A;+8;W<6[151MKYFO&!\WPMF2BY]^'8-RJ#7 M4B54V=&TTT'G;;L\'=F/&L#\P!:9NX=K&/Z!^[L ]&H0@ $G6H]G$R/CIYLU M@\2A6.3_,1Q%%?O3 BLHARY]D$O"A#\:9;8U"X.O:YU$I$S)+A3_:R2*U^.[ MCY-'>S5:+J7(&KHG*IM/=5KNZGA/U61AM7VBR^GK)?0 NBL.+ET5AOW9_R<% MP-^-[W=:; M#BA@WZEN8#C[N.'\KB#_:+#/G"7F,]-'6V/Y)/'8 AB1/RL@_LE+'I""QRA8 M;VS[B?-AR,F\G.N)"1!L%Y5LJ2PLM!^HCA5;.4 5A(\LL2\1YX$N$8DT0CS0 M.7.ICG-EKR$\9'B*8(_J9PTB0=E(H;@1(B7\@:ZDJHC L240_(^U %\F$HGW M/U.B#%5\ T%>, 92?U,+ZAZI6+,2.Z_2S(&"D"]: ]'_O1;H?6*1V$\6E'-W M/YX(4+\OLP?R_ZD6_/V":Q"!VVFX(2J1M1/="(Q'S(=$[[U:&B/E=V8/G"] MQ!S*'C>;K=2+RO_?E"@P_0-C*'O$CD=#U;W03(EXPA2+'S5Z#.E&8WRNV)&HS87'U>%*TA5+'S5G#2E&P M/Y+U*+%NLQG;+AZKIN\M @T";L(*THT2BY&(I5K)@[O6 YG:,W0SD$EPV*\H M"(T+;B9[!@.4Z-PDB>6F=_\Y)=U03$K-P4^Q:A")@-Z:\.^=Q[\'YX^;X5;J MK0G__GG\^W#^N%ENI5Y,_@/[<:P>Y8OG\;G7&,H>-\NMT(I)/O-_K.Z5?&;; ME?=5^ LEH#&H0_(;5HUZ"FQG!)#^GUM"P=,FED&=%V8^D9S%S# Q_V0]5XSPHO/031.+4CXJ;;FSZZS=^> :A@!86.FTSZU%T8\F?YJ(A[^\1DLYQ* M[M]94VH(18V;.@8T7ICVD1_EG$],H(1Q<\9274C#Q>TZ7A QI_[%&.664-*X M.61()=KX/ >-S_,SQV?<7-*G#@GR=NV\/I%N@#FB^] M/3+;-N5>8J26F1]#^Z&JPI4C_+.Y9H1LE%E\D M3RTNE:V&59ZSPF,*95^'YYT>G3@+4+=KO??7I^T;[4+H?26@$:C#@\^P:J0E M>8:Z]X2Q9_J!&++S,!0(7PEH(.KP$#2L&FVC@1I8!7,9?O)_8@C%7H>%P:4: M46A/EH3S]ZFV+NO@L'-B"*5=AQ7 I1I1:-\NJ9K;\>ZCDB]FL=M#&Z+N*0"E M7X=UOD'-.%%8OV[EW^XJ#(:@Q!K\RH@Z\/>JQ7H[2AR[=2';R[Y(B/+@#]E# M U"/#:Q^Q1<.P=@LJ#J<=67../=#:SBJ2T'#@9L(0]7C7(@/WJH0O X?V4'! MUR'E+5.(LP$MG7(6#[DDP?G]D1D4=!WRVQ)]*)S?$_&DTI6)-_=*QI2ZYSIZ M?_X!,BQ@!=#8U"'S/8L)SAV)US=A9J^_U./49']#P/H7O"\1+ >-41V28@@! MI+F3?MTU1Y/WFP-O04GDH!BD,#58]W0H%YE,3K7;L@T#;Y M9+_=?>-^N+^-8(_\%U!+ 0(4 Q0 ( ,Y*@EB_2_YG#$P+3$N:'1M4$L! A0#% @ SDJ"6.9+,H,. M-0 U'$! D ( !FA0 &5X,RTQ+FAT;5!+ 0(4 Q0 ( M ,Y*@EATJF=8X1L $#V + " <]) !F;W)M."UK+FAT M;5!+ 0(4 Q0 ( ,Y*@ECLD!M0V0, 8/ 1 " =EE M !L9W-T+3(P,C0P,S(W+GAS9%!+ 0(4 Q0 ( ,Y*@E@XQ_N3# D --H M 5 " >%I !L9W-T+3(P,C0P,S(W7V1E9BYX;6Q02P$" M% ,4 " #.2H)86%><9Q,, "XD %0 @ $@

XML 19 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001860871 2024-03-27 2024-03-27 0001860871 LGST:CommonStockParValue0.0001PerShareMember 2024-03-27 2024-03-27 0001860871 LGST:WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember 2024-03-27 2024-03-27 iso4217:USD shares iso4217:USD shares false --12-31 0001860871 8-K 2024-03-27 Tevogen Bio Holdings Inc. DE 001-41002 85-1284695 15 Independence Boulevard Suite #410 Warren NJ 07059 877 838-6436 false false false false Common Stock, par value $0.0001 per share TVGN NASDAQ Warrants, each exercisable for one share of Common Stock for $11.50 per share TVGNW NASDAQ true false